Ephedrine Alkaloid/Caffeine Combos Risk Unproven - Metabolife
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposed ban on the marketing of ephedrine alkaloid and caffeine combination products lacks substantiating data and should be withdrawn by the agency, according to supplement marketer Metabolife.
You may also be interested in...
Ephedrine Supplement Risks, Outcome Variables Subject Of USPHS Meeting
A government public health expert panel will hear comments on whether ephedrine alkaloid-containing dietary supplements labeled for weight loss and exercise pose risks to consumers at an Aug. 8-9 meeting in Washington, D.C. The meeting is being sponsored by the Office of Women's Health.
Ephedrine Alkaloid Products Linked To AERs In 78% Of Cases - CDER
The number of ephedrine alkaloid-containing dietary supplements available for sale in the U.S. has more than tripled during the last five years, a Center for Food Safety & Applied Nutrition survey finds.
Ephedrine Alkaloid Weight-Loss Claims Proposed Ban Lifted By FDA
FDA is withdrawing a proposed prohibition on claims that promote long-term use of ephedrine alkaloid-containing dietary supplements, such as claims for weight loss and bodybuilding.